Moderna Therapeutics, US May 2018
Moderna Therapeutics is a biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). By 2017 the company was said to have a $5B
Moderna Therapeutics is a biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). By 2017 the company was said to have a $5B
We are pleased to announce a new addition into the Agaram Technologies’ global distributor network, in the name of Infowiz.
Hindustan Petroleum Corporation Limited (HPCL) R&D Green Center, Bangalore, has chosen Agaram Technologies’ Qualis LIMS, Logilab ELN and Logilab SDMS as the preferred solution to automate its R&D Laboratories. This
Aarti Drugs chose Agaram’s Logilab ELN & Logilab SDMS for its 21 CFR Part 11 compliance, Data Integrity at their R&D division in Tarapur.
Marking a significant milestone, Agaram Technologies has collaborated with Roquette France, a global leader in plant-based ingredients by choosing Logilab SDMS (Scientific Data Management Systems) as their instrument integration and
Agaram Technologies, a leader in laboratory informatics, is excited to announce a new strategic partnership with PlantOPS, USA. This collaboration aims to integrate advanced data management solutions with PlantOPS’s expertise
Agaram Technologies, is thrilled to announce a strategic partnership with RITME Scientific Solutions, a prominent software distributor and implementor based in France. This collaboration marks a significant milestone for both
A Laboratory Information Management System (LIMS) is software designed to efficiently manage samples and associated data in laboratories. It enables workflow automation, integration with instruments, and centralised access to quality control data.
We are delighted to extend an invitation to our upcoming free online webinar titled, “How Logilab ELN is Winning the trust of the USFDA for Data Integrity & Compliance” This
As with most digital management regulations, 21 CFR (Code of Federal Regulations) issued by United States Food and Drug Administration (FDA) can seem complicated if the regulatory organizations are not